Clinical Trial Update: Assessment of Platelet-derived GARP in Atherosclerotic Disease

View source ↗

Summary

Clinical trial update evaluating platelet-derived GARP as a target in atherosclerotic disease. The study status is NOT_YET_RECRUITING.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Carotid Artery Atherosclerosis

Snippet

Sponsor: Université Catholique de Louvain | Conditions: Atheroma; Carotid Artery, Atheromatosis | Status: NOT_YET_RECRUITING